N Takasu Selected Research

N Takasu Research Topics

Disease

4	Hyperthyroidism 11/2001 - 10/2000
3	Graves Disease (Basedow Disease) 06/2007 - 10/2000
3	Hypothyroidism 07/2006 - 08/2000
3	Obesity 03/2005 - 01/2000
2	Type 2 Diabetes Mellitus (MODY) 05/2007 - 01/2000
2	Body Weight (Weight, Body) 05/2002 - 01/2000
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2001 - 04/2000
1	Left Ventricular Dysfunction 05/2007
1	Tuberculous Peritonitis 07/2006
1	Lymphadenopathy 07/2006
1	Ascites 07/2006
1	Granuloma 07/2006
1	Thyroiditis 07/2006
1	Liver Abscess 07/2006
1	Insulinoma 03/2006
1	Hyperglycemia 03/2005
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2005
1	Lymphoma (Lymphomas) 01/2005
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2005
1	Necrosis 01/2005
1	Neoplasms (Cancer) 01/2005
1	Pain (Aches) 09/2004
1	Diabetic Neuropathies (Diabetic Neuropathy) 09/2004
1	Hepatitis B 11/2003
1	Pancreatitis 11/2003
1	Glucose Intolerance 12/2001
1	Cardiomegaly (Heart Hypertrophy) 11/2001
1	Myocardial Stunning (Stunned Myocardium) 09/2001
1	Teratocarcinoma 03/2001
1	Diabetes Mellitus 01/2001
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 12/2000
1	Hypoglycemia (Reactive Hypoglycemia) 04/2000
1	Hypertension (High Blood Pressure) 03/2000
1	Morbid Obesity 01/2000

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 03/2005 - 04/2000
2	Immunoglobulin E (IgE)IBA 06/2007 - 08/2001
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2001 - 03/2000
2	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2001 - 08/2000
2	Thyroid-Stimulating ImmunoglobulinsIBA 04/2001 - 10/2000
2	thyroid stimulation-blocking antibodyIBA 04/2001 - 08/2000
1	InterleukinsIBA 06/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2007
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2006
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2006
1	Coloring Agents (Dyes)IBA 03/2006
1	PalmitatesIBA 03/2006
1	Oleic Acid (Oleate)IBA 03/2006
1	Metformin (Glucophage)FDA LinkGeneric 03/2005
1	Glucose (Dextrose)FDA LinkGeneric 03/2005
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2005
1	Death Domain ReceptorsIBA 01/2005
1	Caspase 8 (Caspase-8)IBA 01/2005
1	LigandsIBA 01/2005
1	Nitroglycerin (Dynamite)FDA LinkGeneric 09/2004
1	Prednisolone (Predate)FDA LinkGeneric 11/2003
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 05/2002
1	Peptides (Polypeptides)IBA 05/2002
1	CilazaprilIBA 11/2001
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2001
1	Drinking WaterIBA 11/2001
1	Propranolol (Inderal)FDA LinkGeneric 11/2001
1	CalciumIBA 09/2001
1	Streptozocin (Streptozotocin)FDA Link 09/2001
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 09/2001
1	Methimazole (Thiamazole)FDA LinkGeneric 08/2001
1	Interleukin-13IBA 08/2001
1	LuciferasesIBA 03/2001
1	Codon (Codons)IBA 01/2001
1	Methionine (L-Methionine)FDA Link 01/2001
1	K-18 conjugate (K18)IBA 01/2001
1	SuperantigensIBA 01/2001
1	AntibodiesIBA 10/2000
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 10/2000
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2000
1	Antithyroid Agents (Antithyroid Drugs)IBA 10/2000
1	Immunoglobulins (Immunoglobulin)IBA 10/2000
1	Glycoside Hydrolase InhibitorsIBA 04/2000
1	voglibose (Basen)IBA 04/2000
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 03/2000
1	AldosteroneIBA 03/2000
1	ReninIBA 03/2000
1	Genetic Markers (Genetic Marker)IBA 01/2000
1	LeptinIBA 01/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000

Therapy/Procedure

3	Therapeutics 01/2005 - 04/2000
1	Intraperitoneal Injections 11/2001
1	Conservative Treatment 12/2000